{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:23:08Z","timestamp":1785583388466,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016114","name":"Zhejiang Medical Association","doi-asserted-by":"crossref","award":["2021ZYC-A05"],"award-info":[{"award-number":["2021ZYC-A05"]}],"id":[{"id":"10.13039\/501100016114","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Medical Doctor Association","award":["YS-2024-1-001"],"award-info":[{"award-number":["YS-2024-1-001"]}]},{"name":"Drug Safety Research Project by Adverse Drug Reactions Journal","award":["ADR2024MS07"],"award-info":[{"award-number":["ADR2024MS07"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504916"],"award-info":[{"award-number":["82504916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project for Building Research Capacity in Digital and Intelligent Health","award":["HJ2024011"],"award-info":[{"award-number":["HJ2024011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11096-025-02028-5","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:09:14Z","timestamp":1761034154000},"page":"1660-1673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness and safety of different antiplatelet therapies for minor ischemic stroke or high-risk transient ischemic attack: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Tingting","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"11","key":"2028_CR1","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1161\/STROKEAHA.120.030898","volume":"51","author":"H Saber","year":"2020","unstructured":"Saber H, Khatibi K, Szeder V, et al. Reperfusion therapy frequency and outcomes in mild ischemic stroke in the United States. Stroke. 2020;51(11):3241\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030898.","journal-title":"Stroke"},{"issue":"9","key":"2028_CR2","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1161\/STROKEAHA.107.513234","volume":"39","author":"SB Coutts","year":"2008","unstructured":"Coutts SB, Hill MD, Campos CR, et al. Recurrent events in transient ischemic attack and minor stroke: What events are happening and to which patients? Stroke. 2008;39(9):2461\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.107.513234.","journal-title":"Stroke"},{"issue":"2","key":"2028_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/STROKEAHA.110.593897","volume":"43","author":"P Khatri","year":"2012","unstructured":"Khatri P, Conaway MR, Johnston KC. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke. 2012;43(2):560\u20132. https:\/\/doi.org\/10.1161\/STROKEAHA.110.593897.","journal-title":"Stroke"},{"issue":"23","key":"2028_CR4","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","volume":"378","author":"P Amarenco","year":"2018","unstructured":"Amarenco P, Lavallee PC, Monteiro Tavares L, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med. 2018;378(23):2182\u201390. https:\/\/doi.org\/10.1056\/NEJMoa1802712.","journal-title":"N Engl J Med"},{"key":"2028_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l895","volume":"364","author":"Y Wang","year":"2019","unstructured":"Wang Y, Johnston SC, Bath PM, et al. Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack. BMJ. 2019;364:l895. https:\/\/doi.org\/10.1136\/bmj.l895.","journal-title":"BMJ"},{"issue":"1","key":"2028_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1215340.","journal-title":"N Engl J Med"},{"issue":"3","key":"2028_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1800410.","journal-title":"N Engl J Med"},{"issue":"1","key":"2028_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao X, Lin J, et al. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA. 2016;316(1):70\u20138. https:\/\/doi.org\/10.1001\/jama.2016.8662.","journal-title":"JAMA"},{"issue":"1","key":"2028_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","volume":"135","author":"Y Pan","year":"2017","unstructured":"Pan Y, Chen W, Xu Y, et al. Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Circulation. 2017;135(1):21\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024913.","journal-title":"Circulation"},{"issue":"3","key":"2028_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","volume":"383","author":"SC Johnston","year":"2020","unstructured":"Johnston SC, Amarenco P, Denison H, et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med. 2020;383(3):207\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1916870.","journal-title":"N Engl J Med"},{"key":"2028_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2211","volume":"365","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chen W, Lin Y, et al. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ (Clin Res Ed). 2019;365:l2211. https:\/\/doi.org\/10.1136\/bmj.l2211.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"6","key":"2028_CR12","doi-asserted-by":"publisher","first-page":"904","DOI":"10.5551\/JAT.64502","volume":"31","author":"HY Huang","year":"2024","unstructured":"Huang HY, Chen JH, Chi NF, et al. Cilostazol plus aspirin vs. clopidogrel plus aspirin in acute minor stroke or transient ischemic attack. J Atheroscler Thromb. 2024;31(6):904\u201316. https:\/\/doi.org\/10.5551\/JAT.64502.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"2028_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/svn-2020-000841","volume":"7","author":"S Kim","year":"2022","unstructured":"Kim S, Kim J-T, Lee JS, et al. Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke. Stroke Vasc Neurol. 2022;7(1):13\u201321. https:\/\/doi.org\/10.1136\/svn-2020-000841.","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"2028_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12883-024-03585-4","volume":"24","author":"X Liu","year":"2024","unstructured":"Liu X, Lv X, Peng Y, et al. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study. J Article BMC Neurol. 2024;24(1):81. https:\/\/doi.org\/10.1186\/s12883-024-03585-4.","journal-title":"J Article BMC Neurol"},{"issue":"5","key":"2028_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4097\/kja.21358","volume":"74","author":"E Ahn","year":"2021","unstructured":"Ahn E, Kang H. Concepts and emerging issues of network meta-analysis. Korean J Anesthesiol. 2021;74(5):371\u201382. https:\/\/doi.org\/10.4097\/kja.21358.","journal-title":"Korean J Anesthesiol"},{"issue":"11","key":"2028_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384. https:\/\/doi.org\/10.7326\/m14-2385.","journal-title":"Ann Intern Med"},{"issue":"5","key":"2028_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/STROKEAHA.114.008632","volume":"46","author":"D Dutta","year":"2015","unstructured":"Dutta D, Bowen E, Foy C. Four-year follow-up of transient ischemic attacks, strokes, and mimics: a retrospective transient ischemic attack clinic cohort study. Stroke. 2015;46(5):1227\u201332. https:\/\/doi.org\/10.1161\/STROKEAHA.114.008632.","journal-title":"Stroke"},{"issue":"11","key":"2028_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","volume":"6","author":"J Kennedy","year":"2007","unstructured":"Kennedy J, Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6(11):961\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(07)70250-8.","journal-title":"Lancet Neurol"},{"issue":"4","key":"2028_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000366115.56266.0a","volume":"41","author":"PM Bath","year":"2010","unstructured":"Bath PM, Cotton D, Martin RH, et al. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in patients with acute ischaemic stroke: A PRoFESS subgroup analysis. Conf Abstr Stroke. 2010;41(4):e262. https:\/\/doi.org\/10.1161\/01.str.0000366115.56266.0a.","journal-title":"Conf Abstr Stroke"},{"issue":"1","key":"2028_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1603060","volume":"375","author":"SC Johnston","year":"2016","unstructured":"Johnston SC, Amarenco P, Albers GW, et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016;375(1):35\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1603060.","journal-title":"N Engl J Med"},{"issue":"1","key":"2028_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40169-019-0223-z","volume":"8","author":"M Khazaei","year":"2019","unstructured":"Khazaei M, Ghasemian F, Mazdeh M, et al. Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack. Clin Transl Med. 2019;8(1):6. https:\/\/doi.org\/10.1186\/s40169-019-0223-z.","journal-title":"Clin Transl Med"},{"issue":"27","key":"2028_CR22","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","volume":"385","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021;385(27):2520\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2111749.","journal-title":"N Engl J Med"},{"issue":"26","key":"2028_CR23","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","volume":"389","author":"Y Gao","year":"2023","unstructured":"Gao Y, Chen W, Pan Y, et al. Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med. 2023;389(26):2413\u201324. https:\/\/doi.org\/10.1056\/NEJMoa2309137.","journal-title":"N Engl J Med"},{"issue":"5","key":"2028_CR24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamaneurol.2024.0146","volume":"81","author":"HS Chen","year":"2024","unstructured":"Chen HS, Cui Y, Wang XH, et al. Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial. JAMA Neurol. 2024;81(5):450\u201360. https:\/\/doi.org\/10.1001\/jamaneurol.2024.0146.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2028_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jocn.2014.05.038","volume":"22","author":"F He","year":"2015","unstructured":"He F, Xia C, Zhang JH, et al. Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke. J Clin Neurosci. 2015;22(1):83\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2014.05.038.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2028_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/strokeaha.118.022691","volume":"50","author":"J-T Kim","year":"2019","unstructured":"Kim J-T, Park M-S, Choi K-H, et al. Comparative effectiveness of aspirin and clopidogrel versus aspirin in acute minor stroke or transient ischemic attack. Stroke. 2019;50(1):101\u20139. https:\/\/doi.org\/10.1161\/strokeaha.118.022691.","journal-title":"Stroke"},{"issue":"11","key":"2028_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.006474","volume":"13","author":"HL Lee","year":"2020","unstructured":"Lee HL, Kim JT, Lee JS, et al. Comparative effectiveness of dual antiplatelet therapy with aspirin and clopidogrel versus aspirin monotherapy in mild-to-moderate acute ischemic stroke according to the risk of recurrent stroke: an analysis of 15 000 patients from a nationwide, multicenter registry. Circ Cardiovasc Qual Outcomes. 2020;13(11):E006474. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.006474.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"2028_CR28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/acn3.51541","volume":"9","author":"H Fan","year":"2022","unstructured":"Fan H, Wang Y, Liu T, et al. Dual versus mono antiplatelet therapy in mild-to-moderate stroke during hospitalization. Ann Clin Transl Neurol. 2022;9(4):506\u201314. https:\/\/doi.org\/10.1002\/acn3.51541.","journal-title":"Ann Clin Transl Neurol"},{"key":"2028_CR29","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10557-023-07468-7","volume":"38","author":"K Zhang","year":"2023","unstructured":"Zhang K, Liu T, Fan H, et al. Dual versus mono antiplatelet therapy in patients with acute mild-to-moderate stroke: a multicentre perspective cohort study. Cardiovasc Drugs Ther. 2023;38:1259\u201370. https:\/\/doi.org\/10.1007\/s10557-023-07468-7.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10123","key":"2028_CR30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/s0140-6736(17)32849-0","volume":"391","author":"PM Bath","year":"2018","unstructured":"Bath PM, Woodhouse LJ, Appleton JP, et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet. 2018;391(10123):850\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(17)32849-0.","journal-title":"Lancet"},{"issue":"8","key":"2028_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104829","volume":"29","author":"H Wang","year":"2020","unstructured":"Wang H, Li X, Liu C, et al. Effects of oral antiplatelet agents and tirofiban on functional outcomes of patients with non-disabling minor acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29(8):104829. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104829.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"12","key":"2028_CR32","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/str.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418. https:\/\/doi.org\/10.1161\/str.0000000000000211.","journal-title":"Stroke"},{"issue":"2","key":"2028_CR33","doi-asserted-by":"publisher","first-page":"CLXXXVII","DOI":"10.1177\/23969873211000877","volume":"6","author":"J Dawson","year":"2021","unstructured":"Dawson J, Merwick \u00c1, Webb A, et al. European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA. Eur Stroke J. 2021;6(2):CLXXXVII\u2013CXCI. https:\/\/doi.org\/10.1177\/23969873211000877.","journal-title":"Eur Stroke J"},{"issue":"1","key":"2028_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1124\/dmd.109.029132","volume":"38","author":"M Kazui","year":"2010","unstructured":"Kazui M, Nishiya Y, Ishizuka T, et al. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos. 2010;38(1):92\u20139. https:\/\/doi.org\/10.1124\/dmd.109.029132.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"2028_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3949\/ccjm.78a.10145","volume":"78","author":"JP Kitzmiller","year":"2011","unstructured":"Kitzmiller JP, Groen DK, Phelps MA, et al. Pharmacogenomic testing: relevance in medical practice. Cleve Clin J Med. 2011;78(4):243\u201357. https:\/\/doi.org\/10.3949\/ccjm.78a.10145.","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"2028_CR36","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s11096-021-01261-y","volume":"43","author":"M Biswas","year":"2021","unstructured":"Biswas M, Rahaman S, Biswas TK, et al. Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis. Int J Clin Pharm. 2021;43(5):1360\u20139. https:\/\/doi.org\/10.1007\/s11096-021-01261-y.","journal-title":"Int J Clin Pharm"},{"issue":"24","key":"2028_CR37","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1001\/jama.2023.7827","volume":"329","author":"HS Chen","year":"2023","unstructured":"Chen HS, Cui Y, Zhou ZH, et al. Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial. JAMA. 2023;329(24):2135\u201344. https:\/\/doi.org\/10.1001\/jama.2023.7827.","journal-title":"JAMA"},{"key":"2028_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2024.1377475","volume":"15","author":"B Qin","year":"2024","unstructured":"Qin B, Fu L, Qin H, et al. Intravenous thrombolysis versus dual antiplatelet therapy for patients with acute minor ischaemic stroke: a systematic review and meta-analysis. Front Pharmacol. 2024;15:1\u20138. https:\/\/doi.org\/10.3389\/fphar.2024.1377475.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2028_CR39","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11239-024-02994-z","volume":"57","author":"P Viana","year":"2024","unstructured":"Viana P, Relvas JH, Cabral TDD, et al. Dual antiplatelet therapy vs alteplase in adult patients with acute minor ischemic stroke: a systematic review and meta-analysis. J Thromb Thrombolysis. 2024;57(6):929\u201335. https:\/\/doi.org\/10.1007\/s11239-024-02994-z.","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"2028_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamaneurol.2021.4514","volume":"79","author":"R Lun","year":"2022","unstructured":"Lun R, Dhaliwal S, Zitikyte G, et al. Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack. JAMA Neurol. 2022;79(2):141\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2021.4514.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2028_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12883-023-03356-7","volume":"23","author":"M Li","year":"2023","unstructured":"Li M, Yang Q, Shi J, et al. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis. BMC Neurol. 2023;23(1):303. https:\/\/doi.org\/10.1186\/s12883-023-03356-7.","journal-title":"BMC Neurol"},{"issue":"6","key":"2028_CR42","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s00415-024-12330-3","volume":"271","author":"G Marinheiro","year":"2024","unstructured":"Marinheiro G, Ara\u00fajo B, Monteiro GA, et al. Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis. J Neurol. 2024;271(6):3030\u20138. https:\/\/doi.org\/10.1007\/s00415-024-12330-3.","journal-title":"J Neurol"},{"issue":"1","key":"2028_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12883-021-02341-2","volume":"21","author":"C Del Giovane","year":"2021","unstructured":"Del Giovane C, Boncoraglio GB, Bert\u00f9 L, et al. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC Neurol. 2021;21(1):319. https:\/\/doi.org\/10.1186\/s12883-021-02341-2.","journal-title":"BMC Neurol"},{"key":"2028_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jns.2019.02.037","volume":"399","author":"R Xiang","year":"2019","unstructured":"Xiang R, Han R, Yang J, et al. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: a network meta-analysis. J Neurol Sci. 2019;399:199\u2013206. https:\/\/doi.org\/10.1016\/j.jns.2019.02.037.","journal-title":"J Neurol Sci"},{"issue":"SA100","key":"2028_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ijs.12269","volume":"9","author":"CJ Estol","year":"2014","unstructured":"Estol CJ, Bath PMW, Gorelick PB, et al. Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial. Int J Stroke. 2014;9(SA100):43\u20137. https:\/\/doi.org\/10.1111\/ijs.12269.","journal-title":"Int J Stroke"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-02028-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02028-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:08:05Z","timestamp":1763554085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-02028-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2028"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-02028-5","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The statement on equal contribution and co-corresponding authors has been added.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was not required for this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}